1.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-OVA-301, ET743-OVA-301, NCT00113607
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-62982, NCT00003939
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-99098, PMAR-ET-019-99, NCI-G00-1761, NCT00005625
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01018, PMAR-ET-B-022-00, NCI-G01-1948, NCT00017030
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01084, PMAR-ET-B-020-99, NCI-G01-2026, NCT00027508
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-STS-201, ET743-STS-201, NCT00060944
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-INT-11, NCT00050414
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-INT-3, NCT00050427
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-USA-1, NCT00050440
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 02-061, NCT00147212
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-0087M, NCT00379145
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014767, NCT00579501
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and older
Sponsor:
Protocol IDs: EORTC-16951, NCT00002904
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 1 to 17
Sponsor: NCI
Protocol IDs: COG-P9972, POG-P9972, NCT00006463
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: ET743-SAR-1001, NCT00102609
|
